• Aprovel 150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	150 mg

  ATC: C09C C09CA C09CA04

• Aprovel 300 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg

  ATC: C09C C09CA C09CA04

• Aubagio 14 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TERIFLUNOMIDE	14 mg

  ATC: L04A L04AK L04AK02

• Aubagio 7 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TERIFLUNOMIDE	7 mg

  ATC: L04A L04AK L04AK02

• Avaxim injectable suspension in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  Hepatitis A antigen	160 U

  ATC: J07B J07BC J07BC02

• Beyfortus 100 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  NIRSEVIMAB	100 mg

  ATC: J06B J06BD J06BD08

• Beyfortus 50 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  NIRSEVIMAB	100 mg

  ATC: J06B J06BD J06BD08

• Coaprovel 150 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	150 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA04

• Coaprovel 300 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA04

• Coaprovel 300 mg/25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA04

• Diftavax suspension for injection in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  DIPHTHERIA TOXOID	2 UI
  TETANUS TOXOID	20 UI

  ATC: J07A J07AM J07AM51

• Duoplavin 75 mg/100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CLOPIDOGREL	75 mg
  ACETYLSALICYLIC ACID	100 mg

  ATC: B01A B01AC B01AC30

• Dupixent 200 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  DUPILUMAB	200 mg

  ATC: D11A D11AH D11AH05

• Dupixent 200 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  DUPILUMAB	200 mg

  ATC: D11A D11AH D11AH05

• Dupixent 300 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  DUPILUMAB	300 mg

  ATC: D11A D11AH D11AH05

• Dupixent 300 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  DUPILUMAB	300 mg

  ATC: D11A D11AH D11AH05

• Efluelda solution for injection in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  INACTIVATED FRACTIONATED INFLUENZA A H1N1 VIRUS	60 Microgramo(s) Hemaglutinina
  INACTIVATED FRACTIONATED INFLUENZA A H3N2 VIRUS	60 Microgramo(s) Hemaglutinina
  INACTIVATED FRACTIONATED INFLUENZA B VIRUS	60 Microgramo(s) Hemaglutinina

  ATC: J07B J07BB J07BB02

• Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion

  Form: powder and solvent for concentrate for solution for infusion

  Active substance	Dosage
  RASBURICASE	1,5 mg

  ATC: V03A V03AF V03AF07

• Hexyon injectable suspension in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  DIPHTHERIA TOXOID	20 UI
  TETANUS TOXOID	40 UI
  Bordetella pertussis toxoid	25 µg
  Bordetella pertussis filamentous hemagglutinin	25 µg
  INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS	40 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS	8 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS	32 U.D. (UNIDADES ANTIGENICAS D)
  Hepatitis B surface antigen	10 µg
  HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP	12 µg

  ATC: J07C J07CA J07CA09

• Hexyon injectable suspension in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  DIPHTHERIA TOXOID	20 UI
  TETANUS TOXOID	40 UI
  Bordetella pertussis toxoid	25 µg
  Bordetella pertussis filamentous hemagglutinin	25 µg
  INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS	40 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS	8 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS	32 U.D. (UNIDADES ANTIGENICAS D)
  Hepatitis B surface antigen	10 µg
  HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP	12 µg

  ATC: J07C J07CA J07CA09

• Hexyon injectable suspension in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  TETANUS TOXOID	40 UI
  Bordetella pertussis toxoid	25 µg
  Bordetella pertussis filamentous hemagglutinin	25 µg
  INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS	40 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS	8 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS	32 U.D. (UNIDADES ANTIGENICAS D)
  Hepatitis B surface antigen	10 µg
  H. INFLUENZAE TYPE B POLYSACCHARIDE TETANUS TOXOID CONJUGATE	12 µg
  DIPHTHERIA TOXOID	20 UI

  ATC: J07C J07CA J07CA09

• Imovax Polio injectable suspension in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS	40 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS	8 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS	32 U.D. (UNIDADES ANTIGENICAS D)

  ATC: J07B J07BF J07BF03

• Iscover 75 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CLOPIDOGREL	75 mg

  ATC: B01A B01AC B01AC04

• Karvea 150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	150 mg

  ATC: C09C C09CA C09CA04

• Karvea 300 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg

  ATC: C09C C09CA C09CA04

• Karvezide 150 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	150 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA04

• Karvezide 300 mg/12.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg
  HYDROCHLOROTHIAZIDE	12,5 mg

  ATC: C09D C09DA C09DA04

• Karvezide 300 mg/25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  IRBESARTAN	300 mg
  HYDROCHLOROTHIAZIDE	25 mg

  ATC: C09D C09DA C09DA04

• Kevzara 150 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  SARILUMAB	150 mg

  ATC: L04A L04AC L04AC14

• Kevzara 200 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  SARILUMAB	200 mg

  ATC: L04A L04AC L04AC14

• Kevzara 200 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  SARILUMAB	200 mg

  ATC: L04A L04AC L04AC14

• Menquadfi solution for injection

  Form: solution for injection

  Active substance	Dosage
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	10 microgramos/ml
  MENINGOCOCCAL GROUP C POLYSACCHARIDE ANTIGEN	10 microgramos/ml
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	10 microgramos/ml
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y	10 microgramos/ml
  TETANUS TOXOID	55 microgramos/ml

  ATC: J07A J07AH J07AH08

• Menquadfi solution for injection

  Form: solution for injection

  Active substance	Dosage
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	10 µg
  MENINGOCOCCAL GROUP C POLYSACCHARIDE ANTIGEN	10 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	10 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y	10 µg
  TETANUS TOXOID	55 µg

  ATC: J07A J07AH J07AH08

• Multaq 400 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  Dronedarone	400 mg

  ATC: C01B C01BD C01BD07

• Plavix 300 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CLOPIDOGREL	300 mg

  ATC: B01A B01AC B01AC04

• Plavix 75 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CLOPIDOGREL	75 mg

  ATC: B01A B01AC B01AC04

• Plavix 75 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CLOPIDOGREL	75 mg

  ATC: B01A B01AC B01AC04

• Praluent 150 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  ALIROCUMAB	150 mg

  ATC: C10A C10AX C10AX14

• Praluent 300 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ALIROCUMAB	300 mg

  ATC: C10A C10AX C10AX14

• Praluent 75 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  ALIROCUMAB	75 mg

  ATC: C10A C10AX C10AX14

• Renagel 800 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  Sevelamer hydrochloride	800 mg

  ATC: V03A V03AE V03AE02

• Renvella 0.8 g powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  Sevelamer Carbonate	0,8 g

  ATC: V03A V03AE V03AE02

• Renvella 2.4 g powder for oral suspension

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  Sevelamer Carbonate	2,4 mg

  ATC: V03A V03AE V03AE02

• Renvella 800 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  Sevelamer Carbonate	800 mg

  ATC: V03A V03AE V03AE02

• Sarclisa 20 mg/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ISATUXIMAB	20 mg

  ATC: L01F L01FC L01FC02

• Stamaril powder and solvent for injectable suspension in pre-filled syringe

  Form: powder and solvent for injectable suspension

  Active substance	Dosage
  YELLOW FEVER VIRUS STRAIN 17D	1000 -

  ATC: J07B J07BL J07BL01

• Taxotere 80 mg/4 ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  DOCETAXEL	80 mg

  ATC: L01C L01CD L01CD02

• TetraXim injectable suspension in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  DIPHTHERIA TOXOID	20 UI
  TETANUS TOXOID	40 UI
  Bordetella pertussis toxoid	25 µg
  Bordetella pertussis filamentous hemagglutinin	25 µg
  INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS	40 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS	8 U.D. (UNIDADES ANTIGENICAS D)
  INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS	32 U.D. (UNIDADES ANTIGENICAS D)

  ATC: J07C J07CA J07CA02

• Thyrogen 0.9 mg powder for solution for injection

  Form: powder for solution for injection

  Active substance	Dosage
  THYROTROPIN ALFA	0,9 mg

  ATC: V04C V04CJ V04CJ01

• Triaxis suspension for injection in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  DIPHTHERIA TOXOID	2 UI
  TETANUS TOXOID	20 UI
  Bordetella pertussis toxoid	2,5 µg
  Bordetella pertussis filamentous hemagglutinin	5 µg
  Bordetella pertussis pertactin	3 µg
  Pertussis fimbriae agglutinogen toxoid	5 µg

  ATC: J07A J07AJ J07AJ52